The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend the targeted breast cancer drug, capivasertib, in combination with fulvestrant, for treating the most ...

A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for some men than the current standard PSA blood test, a new study reports. Results ...

The Oncogenetics group have three sub-groups working alongside each other: the lab group of scientists and clinical fellows, the data group of scientists and administrators and the clinical group of ...

The ICR, in collaboration with The Royal Marsden NHS Foundation Trust, has now taken delivery of the latest genome sequencing device, the NovaSeq X Plus. In this blog post, Mark Jones speaks with ...

Breast cancer remains a leading cause of cancer-related deaths globally, with triple-negative breast cancer (TNBC) presenting particular therapeutic challenges due to its aggressive nature and limited ...

"Search" is our twice-yearly newsletter to supporters. In our latest edition of Spring Search issue, we look at the latest research news including how our scientists are developing improved breast ...

Image: QBiotics' scientists isolated tiglanol tiglate after observations that the musky rat-kangaroo (pictured) found the seeds of the blushwood tree unpalatable. Credit Charles J Sharp, ...

Scientists have unveiled a cutting-edge research platform powered by artificial intelligence (AI) that will revolutionise cancer research by allowing researchers to integrate and analyse large and ...

In the largest and most comprehensive study of its kind, researchers have provided further evidence that a hormone responsible for regulating breast development acts as a risk factor for breast cancer ...

Nadia, 28, is running her third London Landmarks half marathon for the ICR. She explains why supporting our vital research is so important to her. When I was 18, I was living in South Africa and was ...